Your browser doesn't support javascript.
loading
Acute pancreatitis as a complication of acute COVID-19 in kidney transplant recipients.
Basic-Jukic, Nikolina; Juric, Ivana; Katalinic, Lea; Furic-Cunko, Vesna; Sesa, Vibor; Mrzljak, Anna.
Affiliation
  • Basic-Jukic N; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
  • Juric I; Department of Medicine, School of Medicine, Zagreb 10000, Croatia. nina_basic@net.hr.
  • Katalinic L; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
  • Furic-Cunko V; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
  • Sesa V; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
  • Mrzljak A; Department of Gastroenterology and Hepatology, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
World J Clin Cases ; 12(6): 1104-1110, 2024 Feb 26.
Article in En | MEDLINE | ID: mdl-38464928
ABSTRACT

BACKGROUND:

Acute pancreatitis is a rare extrapulmonary manifestation of coronavirus disease 2019 (COVID-19) but its full correlation with COVID-19 infection remains unknown.

AIM:

To identify acute pancreatitis' occurrence, clinical presentation and outcomes in a cohort of kidney transplant recipients with acute COVID-19.

METHODS:

A retrospective observational single-centre cohort study from a transplant centre in Croatia for all adult renal transplant recipients with a functioning kidney allograft between March 2020 and August 2022 to record cases of acute pancreatitis during acute COVID-19. Data were obtained from hospital electronic medical records. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was proven by a positive SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction on the nasopharyngeal swab.

RESULTS:

Four hundred and eight out of 1432 (28.49%) patients who received a renal allograft developed COVID-19 disease. The analyzed cohort included 321 patients (57% males). One hundred and fifty patients (46.7%) received at least one dose of the anti-SARS-CoV-2 vaccine before the infection. One hundred twenty-five (39.1%) patients required hospitalization, 141 (44.1%) developed pneumonia and four patients (1.3%) required mechanical ventilation. Treatment included immunosuppression modification in 233 patients (77.1%) and remdesivir in 53 patients (16.6%), besides the other supportive measures. In the study cohort, only one transplant recipient (0.3%) developed acute pancreatitis during acute COVID-19, presenting with abdominal pain and significantly elevated pancreatic enzymes. She survived without complications with a stable kidney allograft function.

CONCLUSION:

Although rare, acute pancreatitis may complicate the course of acute COVID-19 in kidney transplant recipients. The mechanism of injury to the pancreas and its correlation with the severity of the COVID-19 infection in kidney transplant recipients warrants further research.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: World J Clin Cases Year: 2024 Document type: Article Affiliation country: Croatia

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: World J Clin Cases Year: 2024 Document type: Article Affiliation country: Croatia